Buruli ulcer: A review of in vitro tests to screen natural products for activity against mycobacterium ulcerans

Planta Medica

Volumn 77, Issue 6, 2011, Pages 641-646

  Yemoa, Achille ^a   Gbenou, Joachim ^b   Affolabi, Dissou ^c   Moudachirou, Mansourou ^b   Bigot, André ^a   Anagonou, Séverin ^c   Portaels, Françoise ^d   Quetin Leclercq, Joëlle ^e   Martin, Anandi ^d  

^a UNIVERSITY OF ABOMEY CALAVI   (Benin)

^b Laboratoire de Pharmacognosie et des Huiles Essentielles (LAPHE)   (Benin)

^c Laboratoire de Référence des Mycobactéries   (Benin)

^d INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^e UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

antimycobacterial; Buruli ulcer; natural products; screening

Indexed keywords

ANCHOMANES DIFFORMIS EXTRACT; ANOGEISSUS LEIOCARPUS EXTRACT; ANTIMYCOBACTERIAL AGENT; BRIDELLIA FERRUGINEA EXTRACT; BRYOPHYLLUM PINNATUM EXTRACT; CHENOPODIUM AMBROSIOIDES EXTRACT; ERYTHROPHLEUM SUAVEOLENS EXTRACT; EUPHORBIA KAMERUNICA EXTRACT; GARCINIA KOLA EXTRACT; HOLARRHENA FLORIBUNDA EXTRACT; HYMENOCARDIA ACIDA EXTRACT; JATROPHA CURCAS EXTRACT; JATROPHA GOSSYPIFOLIA EXTRACT; KEDROSTIS FOEDISS EXTRACT; LANNEA KERSTINGII EXTRACT; LAUNAEA TARAXACIFOLIA EXTRACT; MONODORA MYRISTICA EXTRACT; NATURAL PRODUCT; NEWBOULDIA LAEVIS EXTRACT; PILIOSTIGMA THONNINGII EXTRACT; PLANT EXTRACT; RITCHIEA CAPPAROIDES EXTRACT; SPATHODEA CAMPANULATA EXTRACT; SPONDIAS MOMBIN EXTRACT; STEREOSPERMMUM KUNTHIANUM EXTRACT; STROPHANTHUS HISPIDUS EXTRACT; TERMINALIA GLAUCESCENS EXTRACT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERNONIA AMYGDALINA EXTRACT; XYLOPIA AETHIOPICA EXTRACT;

AGAR DIFFUSION; AGAR DILUTION; BACTERIAL GROWTH; BARK; BROTH DILUTION; BURULI ULCER; DRUG SCREENING; FRUIT; IN VITRO STUDY; MEDICINAL PLANT; MYCOBACTERIUM ULCERANS; NONHUMAN; PLANT BULB; PLANT LEAF; PLANT ROOT; PLANT SEED; PLANT STEM; RADIORESPIROMETRY; REVIEW; RHIZOME; SCREENING TEST;

ANTI-BACTERIAL AGENTS; BIOLOGICAL AGENTS; BIOLOGICAL ASSAY; BURULI ULCER; COLONY COUNT, MICROBIAL; DRUG EVALUATION, PRECLINICAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM ULCERANS; PLANT EXTRACTS; RADIOMETRY;

MYCOBACTERIUM ULCERANS;

EID: 79954623247     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0030-1250642     Document Type: Review

References (42)

1. Asiedu K, Scherpbier R, Raviglione M. Ulcère de Buruli: infection à Mycobacterium ulcerans. Belgium OMS 2000
2. Josse R, Guédénon A, Darie H, Anagonou S, Portaels F, Meyers W M. Les infections cutanées à Mycobacterium ulcerans: ulcères de Buruli. Med Trop 1995 55 363-373 (Pubitemid 26101619)
3. Johnson P D., Veitch M G., Flood P E., Hayman J A. Mycobacterium ulcerans infection on Phillip Island, Victoria. Med J Aust 1995 162 221-222
4. Marston B J., Diallo M O., Horsburgh Jr C R., Diomande I, Saki M Z., Kanga J M., Patrice G, Lipman H B., Ostroff S M., Good R C. Emergence of Buruli ulcer disease in the Daloa region of Côte d'Ivoire. Am J Trop Med Hyg 1995 52 219-224
5. Chauty A, Ardant M F., Adeye A, Euverte H, Guédénon A, Johnson C, Aubry J, Nuermberger E, Grosset J. Promising clinical efficacy of streptomycin-rifampin combination for treatment of buruli ulcer (Mycobacterium ulcerans disease). Antimicrob Agents Chemother 2007 51 4029-4035 (Pubitemid 350057802)
6. Nienhuis W A., Stienstra Y, Thompson W A., Awuah P C., Abass K M., Tuah W, Awua-Boateng N Y., Ampadu E O., Siegmund V, Schouten J P., Adjei O, Bretzel G, van der Werf T S. Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomized controlled trial. Lancet 2010 37 664-672
7. Johnson P D. Should antibiotics be given for Buruli ulcer? Lancet 2010 20 664-672
8. Kibadi K, Boelaert M, Fraga A G., Kayinua M, Longatto-Filho A, Minuku J B., Mputu-Yamba J B., Muyembe-Tamfum J J., Pedrosa J, Roux J J., Meyers W M., Portaels F. Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli ulcer (Mycobacterium ulcerans disease). PloS Negl Trop Dis 2010 4 e736
9. Johnson R C., Makoutode M, Hougnihin R, Guédénon A, Ifebe D, Boko M, Portaels F. Le traitement traditionnel de l'ulcère de Buruli au Bénin. Med Trop 2004 64 145-150
10. Guédénon A, Zinsou C, Josse R, Andélé K, Portaels F. Traditional treatment of Buruli ulcer in Benin. Arch Dermatol 1995 131 741-742
11. Yemoa A L., Gbenou J D., Johnson R C., Djego J G., Zinsou C, Moudachirou M, Quetin-Leclercq J, Bigot A, Portaels F. Identification et étude phytochimique de plantes utilisées dans le traitement traditionnel de l'ulcère de Buruli au Bénin. Ethnopharmacologia 2008 42 50-57
12. Kone M, Vangah-Mandah O M., Kouakou H, Yapo A P., Bleyere N M., Datte Y J., N'guessan B B., Joulia E D., D'Horpock A F., Ehile E E. Influence de Sacoglottis gabonensis (Baille) urban et de Okoubaka aubrevillei normand et pellegrin sur la croissance in vitro de Mycobacterium ulcerans. Le pharmacien d'Afrique 2007 206 17-22
13. Cos P, Vlietinck A J., Berghe D V., Maes L. Anti-infective potential of natural products: how to develop a stronger in vitro proof-of-concept'. J Ethnopharmacol 2006 106 290-302 (Pubitemid 43949328)
14. Sawai J, Doi R, Maekawa Y, Yoshikawa T, Kojima H. Indirect conductimetric assay of antibacterial activities. J Indian Microbiol Biotechnol 2002 29 296-298 (Pubitemid 35379602)
15. Verkman A S. Drug discovery in academia. Am J Physiol Cell Physiol 2004 286 465-474
16. Gautam R, Saklani A, Jachak S M. Indian medicinal plants as a source of antimycobacterial agents. J Ethnopharmacol 2007 110 200-234
17. Portaels F, Traore H, de Ridder K, Meyers W M. In vitro susceptibility of Mycobacterium ulcerans to clarithromycin. Antimicrob Agents Chemother 1998 42 2070-2073 (Pubitemid 28363095)
18. Bueno-Sánchez J G., Kouznetsov V V. Antimycobacterial susceptibility testing methods for natural products research. Braz J Microbiol 2010 41 270-277
19. Nostro A, Germano M P., D'Angelo V, Marino A, Cannatelli M A. Extraction methods and bioautography for evaluation of medicinal plant antimicrobial activity. Lett Microbiol 2000 30 379-384 (Pubitemid 30259046)
20. Silva M T., Simas S M., Batista T G., Cardarelli P, Tomassini T C. Studies on antimicrobial activity, in vitro, of Physalis angulata L. (Solanaceae) fraction and physalin B bringing out the importance of assay determination. Mem Inst Oswaldo Cruz 2005 100 779-782 (Pubitemid 43154815)
21. Barker L P., Lien B A., Brun O S., Schaak D D., McDonough K A., Chang L C. A Mycobacterium marinum zone of inhibition assay as a method for screening potential antimycobacterial compounds from marine extracts. Planta Med 2007 73 559-563 (Pubitemid 46984843)
22. Connell N D., Nikaido H. Membrane permeability and transport in Mycobacterium tuberculosis. Bloom BR Tuberculosis: pathogenesis, protection and control. Washington American Society of Microbiology 1994 333-452
23. Palomino J C., Obiang A M., Realini L, Meyers W M., Portaels F. Effect of oxygen on growth of Mycobacterium ulcerans in the BACTEC system. J Clin Microbiol 1998 36 3420-3422 (Pubitemid 28476212)
24. Cantrell C L., Fischer N H., Urbatsch L, McGuire M S., Franzblau S G. Antimicrobial crude plant extracts from South, Central, and North America. Phytomedicine 1998 5 137-145 (Pubitemid 128566315)
25. Rajab M S., Cantrell C L., Franzblau S G., Fischer N H. Antimycobacterial activity of (E)-phytol and derivatives: a preliminary structure activity study. Planta Med 1998 64 2-4 (Pubitemid 28059987)
26. Sanders C A., Nieda R R., Desmond E P. Validation of the use of Middlebrook 7H10 agar, BACTEC MGIT 960, and BACTEC 460 12B media for testing the susceptibility of Mycobacterium tuberculosis to levofloxacin. J Clin Microbiol 2004 42 5225-5228 (Pubitemid 39506233)
27. Diaz-Infantes M S., Ruiz-Serrano M J., Martinez-Sànchez L, Ortega A, Bouza E. Evaluation of the MB/BacT Mycobacterium detection system for susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 2000 38 1988-1989 (Pubitemid 30253952)
28. Ruiz P, Zerolo F J., Casal M J. Comparison of susceptibility testing of Mycobacterium tuberculosis using the ESP culture system II with that using the BACTEC method. J Clin Microbiol 2000 38 4663-4664 (Pubitemid 32244572)
29. Ji B, Lefrançois S, Robert J, Chauffour A, Truffot C, Jarlier V. In vitro and in vivo activities of rifampin, streptomycin, amikacin, moxifloxacin, R207910, linezolid, and PA-824 against Mycobacterium ulcerans. Antimicrob Agents Chemother 2006 50 1921-1926 (Pubitemid 43807506)
30. Chand S, Lusunzi I, Veal D A., Williams L R., Karuso P. Rapid screening of the antimicrobial activity of extracts and natural products. J Antibiot 1994 47 1295-1304 (Pubitemid 24373407)
31. Clarke J M., Gillings M R., Altavilla N, Beattie A J. Potential problems with fluorescein diacetate assays of cell viability when testing natural products for antimicrobial activity. J Microbiol Methods 2001 46 261-267 (Pubitemid 32579215)
32. Franzblau S G., Witzig R S., McLaughlin J C., Torres P, Madico G, Hernandez A, Degnan M T., Cook M B., Quenzer V K., Ferguson R M., Gilman R H. Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J Clin Microbiol 1998 36 362-366 (Pubitemid 28060296)
33. Collins L, Franzblau S G. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob Agents Chemother 1997 41 1004-1009 (Pubitemid 27194176)
34. Palomino J C., Martin A, Camacho M, Guerra H, Swings J, Portaels F. Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2002 46 2720-2722 (Pubitemid 34793497)
35. Martin A, Portaels F, Palomino J C. Colorimetric redox-indicator methods for the rapid detection of multidrug resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother 2007 59 175-183 (Pubitemid 47072054)
36. Martin A, Camacho M, Portaels F, Palomino J C. Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple, and inexpensive method. Antimicrob Agents Chemother 2003 47 3616-3619 (Pubitemid 37345731)
37. Abate G, Mshana R N., Miorner H. Evaluation of a colorimetric assay based on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 1998 2 1011-1016 (Pubitemid 29005219)
38. Caviedes L, Delgado J, Gilman R H. Tetrazolium microplate assay as a rapid and inexpensive colorimetric method for determination of antibiotic susceptibility of Mycobacterium tuberculosis. J Clin Microbiol 2002 40 1873-1874 (Pubitemid 34493180)
39. Foongladda S, Roengsanthia D, Arjrattanakool W, Chuchottaworn C, Chaiprasert A, Franzblau S G. Rapid and simple MTT method for rifampicin and isoniazid susceptibility testing of Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2002 6 1118-1122 (Pubitemid 36054968)
40. Gordien A Y., Gray A I., Franzblau S G., Seidel V. Antimycobacterial terpenoids from Juniperus communis L. (Cuppressaceae). J Ethnopharmacol 2009 126 500-505
41. European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution. Clin Microbiol Infect 2003 9 ix-xv
42. Ncube N S., Afolayan A J., Okoh A I. Assessment techniques of antimicrobial properties of natural compounds of plant origin: current methods and future trends. Afr J Biotechnol 2008 7 1797-1806 (Pubitemid 351919121)